Melanotan 2 and PT-141 share a common origin and receptor system, but research interest in each has diverged toward distinct questions. Understanding the relationship between them explains why they're often discussed together despite being studied for different purposes.
A shared starting point
Both compounds are synthetic analogs of alpha-melanocyte-stimulating hormone (α-MSH), a natural signaling molecule that activates the melanocortin receptor family (MC1R through MC5R) across a range of physiological pathways — from pigmentation to appetite regulation to sexual arousal circuits in the central nervous system.
Melanotan 2 (MT-II)
Melanotan 2 is a non-selective melanocortin receptor agonist, meaning it activates multiple receptor subtypes rather than one specifically. Much of the original research interest centered on MC1R activation and its role in melanogenesis (pigmentation) pathways, though as a non-selective compound it also engages MC3R and MC4R, which is part of why its research applications span a broader range than pigmentation alone.
PT-141 (Bremelanotide)
PT-141 was developed as a more targeted derivative in the same research program that produced Melanotan 2, with greater selectivity for MC4R specifically. This receptor is heavily implicated in central nervous system pathways related to sexual arousal, which is why PT-141's research trajectory diverged toward that specific mechanism rather than the broader multi-receptor profile of its predecessor.
Why they're often discussed together
Because PT-141 was derived directly from Melanotan 2's development pathway, researchers frequently reference both compounds when discussing melanocortin receptor selectivity — MT-II as the non-selective parent compound, PT-141 as the example of what receptor-specific refinement looks like within the same family.
Sourcing
Both compounds are available with third-party purity and identity verification. Given their structural similarity, confirming you have the correct compound — not just the correct concentration — is worth double-checking against your Certificate of Analysis.